Pallas Capital Advisors LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1862282
BRAINTREE, MA
Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,197,196
-$873,479 QoQ
Shares Held
1,920
-28.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#614
of 1,329 holders
Holding Since
Sep 2021
7 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $30,351,010 across 36 Biotechnology names. REGN ranks #5 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
40,511 | $9,915,877 | |
| 2 | RPRX |
Royalty Pharma plc
|
108,585 | $6,088,360 | |
| 3 | INCY |
Incyte Corp
|
32,151 | $3,644,637 | |
| 4 | EXEL |
Exelixis, Inc.
|
30,721 | $1,671,529 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,920 | $1,197,196 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,200 | $1,092,806 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
39,499 | $687,282 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,203 | $663,169 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,197,196 | 1,920 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,070,675 | 2,680 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,486,965 | 3,222 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,316,836 | 2,342 | Shares | Sole | 2025-11-07 | |
| 2025-03-31 | $425,568 | 671 | Shares | Sole | 2025-04-14 | |
| 2021-12-31 | $335,337 | 531 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $462,357 | 764 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||